Fig. 2From: Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cellsEndothelial cell density (mm2) before (blue) and after (red) incubation with ranibizumab (Lucentis®) or bevacizumab (Avastin®)Back to article page